Tommy Nørskov Johansen

Tommy Nørskov Johansen serves as Associate Professor in the Department of Drug Design and Pharmacology at the University of Copenhagen, specializing in medicinal chemistry and neuropharmacology. His research focuses on designing receptor antagonists for kainate and AMPA receptors, with applications in neurological disorders and pain management. He maintains an active publication record with 50+ research outputs and has been referenced in 2 patents.

Research interests span Medicinal Chemistry, Pharmacology, Neuropharmacology, Drug Design, Receptor Antagonists, and Structure-Activity Relationships. His work emphasizes developing selective compounds through molecular design, synthesis, and pharmacological evaluation, particularly targeting ionotropic glutamate receptors for therapeutic applications.

Analysis of his 2017-2024 publications reveals a strong trajectory in kainate receptor antagonist development using quinoxaline-2,3-dione scaffolds. Recent work (2021-2024) demonstrates expanded scope into radioligand development and Keap1 inhibitors, reflecting evolving expertise from target identification to translational drug discovery.

Academic engagement includes organizing clinical pharmacy workshops (2023-2024) and delivering lectures on stereochemistry since 2007. His research impact is evidenced by 54+ Mendeley readers and patent citations, though formal awards are not documented in available sources.